ChemTrak Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ChemTrak

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: William Presti who wrote (16)	10/16/1996 10:28:00 AM
From: Musti	of 48

I agree completely on your positive assessment of CMTR. I believe this stock has simply drifted (been ignored) down to its current $2+ price. I believe that CMTR is about to fire on all cylinders -- (1) their cholesterol test and its wide distribution will be paying dividends over the next months/years; (2) their ulcer test being sold by Merck -- I believe this agreement is being very underrated by all, it was initially announced over a year ago prior to CMTR's FDA approval for the kit, no reason why this won't be a "big deal" for CMTR; (3) the pending HIV approval and subsequent distribution agreements; (4) whatever new stuff is in the pipeline -- almost irrelevent since even moderate success on the existing lines I expect would easily pull the stock back to its 4-5 level and then upwards from there as ongoing sales occur. This company only has 10m shares outstanding -- thus, CMTR is currently being valued at $20m !! As a value investor, I consider this to be one incredible buying opportunity -- extremely limited downside risk with tremendous upside potential.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next